May 12, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Practice Management, Type 2 Diabetes, Type 2 Diabetes 1,345 views A patient starts semaglutide through a telehealth platform, receives nutrition advice from a wellness clinic, and later visits a primary care physician for worsening gastrointestinal symptoms
Global Health Estimates
Peripheral neuropathy Antiretroviral-related peripheral neuropathy The use of certain antiretroviral agents (nucleoside analogs) has been associated with an increased risk of developing peripheral neuropathy in HIV-positive individuals (77, 78)
These spots are not contagious, not painful, and do not affect sexual health
For many people, long-term use is the realistic expectation if sustained benefit is the goal